Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01336 NCI
RTNominal up32.100 +0.150 (+0.469%)
Others

05/11/2019 14:20

{I-bank focus}HSBC downgrades NCI (01336) to "hold" & HK$33

[ET Net News Agency, 5 November 2019] HSBC Global Research lowered its target price for
New China Life (NCI)(01336) to HK$33 from HK$44 and downgraded its rating to "hold" from
"buy".
The research house said NCI is the purest life play in its coverage universe, offering
exposure to China's growing life insurance market. It has delivered an impressive progress
in executing its transformation plan to cut the proportion of lower margin single premium
investment products sold through the bancassurance channel.
However, agency growth has lagged peers in the past three years and productivity
improvements will take time. Whether NCI will continue to focus on value under the new
management is unclear. HSBC expects it to deliver 13% embedded value and 0% life new
business value growth over 2018-21. (KL)

Remark: Real time quote last updated: 24/01/2020 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2020 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.